Suchergebnisse - "González-Martín, Antonio"

PubPharm (262)

1

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Boidot, R. | Blum, M. | Wissler, M. | +21

2

Retrospective Multicenter Study of Elderly Patients With Platinum-Sensitive Relapsed Ovarian Cancer Treated With Trabectedin and Pegylated Liposomal Doxorubicin (Pld) in a Real- World Setting: A Geico Study

enthalten in: ResearchSquare.com | 2024

von Rubio, M. | Manzano, A. | de Sande, L. | +12

3

Progression-free survival and safety at 3.5 years of follow-up : results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary

enthalten in: Future oncology (London, England) | 2024

von González-Martín, A. | Pothuri, B. | Vergote, I. | +15

4

An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Chiva, L. | Ordás, P. | Martin-Calvo, N. | +10

5

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

enthalten in: Bulletin du cancer | 2024

von Harter, P. | Bogner, G. | Chiva, L. | +21

6

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo : Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

enthalten in: Gynecologic oncology | 2024

von Pothuri, B. | Han, S. | Chase, D. | +23

7

Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Tavira, B. | Iscar, T. | Manso, L. | +12

CommentIn: Clin Cancer Res. 2024 Jan 5;30(1):12-16. - PMID 37939000

8

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors : Primary Results From the DESTINY-PanTumor02 Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Meric-Bernstam, F. | Makker, V. | Oaknin, A. | +15

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF10. - PMID 37888905

9

GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles

enthalten in: Cell reports. Medicine | 2023

von Pozzorini, C. | Andre, G. | Coletta, T. | +33

10

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer

enthalten in: bioRxiv.org | 2023

von Boidot, R. | Blum, M. | Wissler, M. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]